| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K |
| P698 | PubMed publication ID | 11817590 |
| P50 | author | Martin Herrmann | Q1528832 |
| P2093 | author name string | Thomas Kirchner | |
| Winfried L Neuhuber | |||
| Joachim R Kalden | |||
| Reinhard E Voll | |||
| Irith Baumann | |||
| Bernhard Manger | |||
| Udo Gaipl | |||
| Wasilis Kolowos | |||
| P433 | issue | 1 | |
| P921 | main subject | apoptotic process | Q14599311 |
| systemic lupus erythematosus | Q1485 | ||
| P304 | page(s) | 191-201 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus | |
| P478 | volume | 46 |
| Q37694471 | 9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus. |
| Q40139958 | A Novel Subset of Anti-Inflammatory CD138+ Macrophages Is Deficient in Mice with Experimental Lupus. |
| Q36246034 | Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity |
| Q33436384 | Abl kinase inhibits the engulfment of apoptotic [corrected] cells in Caenorhabditis elegans |
| Q33851587 | Abnormal production of pro- and anti-inflammatory cytokines by lupus monocytes in response to apoptotic cells |
| Q38799583 | Acceleration of tumor growth due to dysfunction in M1 macrophages and enhanced angiogenesis in an animal model of autoimmune disease |
| Q50042918 | Accomplices of the Hypoxic Tumor Microenvironment Compromising Antitumor Immunity: Adenosine, Lactate, Acidosis, Vascular Endothelial Growth Factor, Potassium Ions, and Phosphatidylserine |
| Q59742253 | Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus |
| Q38546315 | An acquired defect in IgG-dependent phagocytosis explains the impairment in antibody-mediated cellular depletion in Lupus |
| Q34848836 | An apoptosis-associated mammary protein deficiency leads to enhanced production of IgM antibodies against multiple damage-associated molecules. |
| Q46720864 | An impaired detection and clearance of dying cells can lead to the development of chronic autoimmunity |
| Q64102174 | Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target |
| Q81556941 | Anti-Sm B cell tolerance and tolerance loss in systemic lupus erythematosus |
| Q35620285 | Anti-class a scavenger receptor autoantibodies from systemic lupus erythematosus patients impair phagocytic clearance of apoptotic cells by macrophages in vitro |
| Q35620345 | Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus |
| Q33802812 | Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice. |
| Q81422425 | Anti-nucleosome antibodies as prediction factor of development of autoantibodies during therapy with three different TNFalpha blocking agents in rheumatoid arthritis |
| Q51065242 | Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study. |
| Q35555094 | Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity |
| Q36535200 | Apoptosis and autoimmunity: when apoptotic cells break their silence. |
| Q55560950 | Apoptotic Cell-Derived Extracellular Vesicles: More Than Just Debris. |
| Q26825935 | Apoptotic cell clearance: basic biology and therapeutic potential. |
| Q36581453 | Apoptotic cell death and lupus |
| Q28385358 | Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity |
| Q34089049 | Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells |
| Q36418402 | Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: Implications for the delayed clearance model of autoimmunity |
| Q55113458 | Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus. |
| Q35772872 | Autoimmunity through cytokine-induced dendritic cell activation |
| Q36618394 | Autoimmunity versus tolerance: can dying cells tip the balance? |
| Q42741742 | Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance |
| Q57030964 | B cell responses to apoptotic cells in MFG-E8-/- mice |
| Q35553367 | B lymphocytes and systemic lupus erythematosus |
| Q37705429 | Breaking immunological tolerance in systemic lupus erythematosus. |
| Q83283956 | C1qRP (CD93) expression on peripheral blood monocytes in patients with systemic lupus erythematosus |
| Q42144063 | CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation. |
| Q42327818 | Capability of Neutrophils to Form NETs Is Not Directly Influenced by a CMA-Targeting Peptide |
| Q48289641 | Cardiolipin activates antigen-presenting cells via TLR2-PI3K-PKN1-AKT/p38-NF-kB signaling to prime antigen-specific naïve T cells in mice |
| Q24626603 | Caspase-activated DNase is required for maintenance of tolerance to lupus nuclear autoantigens |
| Q50034731 | Cell Death, Nucleic acids and Immunity: Inflammation beyond the Grave |
| Q38926368 | Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis |
| Q34069145 | Cellular regulation of the inflammatory response |
| Q38237868 | Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus |
| Q37624992 | Chapter 7: Cell protective functions of secretory Clusterin (sCLU). |
| Q101350963 | Checkpoints controlling the induction of B cell mediated autoimmunity in human autoimmune diseases |
| Q28278631 | Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner |
| Q35677438 | Circulating IgM Requires Plasma Membrane Disruption to Bind Apoptotic and Non-Apoptotic Nucleated Cells and Erythrocytes |
| Q26767511 | Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE |
| Q30276066 | Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis. |
| Q37777666 | Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system |
| Q57809694 | Comparing the effects of different cell death programs in tumor progression and immunotherapy |
| Q41987402 | Comparison of apoptosis detection markers combined with macrophage immunostaining to study phagocytosis of apoptotic cells in situ |
| Q36880118 | Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease |
| Q42553556 | Consensus guidelines for the detection of immunogenic cell death |
| Q28397407 | Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity |
| Q36134951 | Cutaneous manifestations of systemic lupus erythematosus. |
| Q42141284 | Cytokine-induced monocyte characteristics in SLE |
| Q36081115 | DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus |
| Q35940062 | Defects in the disposal of dying cells lead to autoimmunity |
| Q36908788 | Dendritic cells and the immunopathogenesis of systemic lupus erythematosus |
| Q33941433 | Dendritic cells in systemic lupus erythematosus |
| Q80805109 | Differential expression in lupus-associated IL-10 promoter single-nucleotide polymorphisms is mediated by poly(ADP-ribose) polymerase-1 |
| Q57468222 | Disassembly of dying cells in diverse organisms |
| Q27334880 | Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging |
| Q34221296 | Disruption of the cytoskeleton after apoptosis induction with autoantibodies |
| Q21195358 | Disturbances of apoptotic cell clearance in systemic lupus erythematosus |
| Q38042950 | Dying cell clearance and its impact on the outcome of tumor radiotherapy |
| Q39303557 | Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus. |
| Q39062993 | Dysregulation of Cell Death and Its Epigenetic Mechanisms in Systemic Lupus Erythematosus. |
| Q37638196 | Dysregulation of germinal centres in autoimmune disease. |
| Q49539707 | Elevated Serum Lysophosphatidylcholine in Patients with Systemic Lupus Erythematosus Impairs Phagocytosis of Necrotic Cells In Vitro |
| Q44855413 | Environment-dependent down-modulation of CD45 cell surface expression on polymorphonuclear cells. |
| Q36647824 | FcgammaRII and multi-system autoimmune disease |
| Q34317151 | Flow cytometric analysis of the LE cell phenomenon |
| Q36972852 | Fundamental role of C1q in autoimmunity and inflammation |
| Q92187401 | Funerals and Feasts: The Immunological Rites of Cell Death |
| Q84522715 | Genetic polymorphism of the growth arrest-specific 6 gene is associated with cutaneous vasculitis in Taiwanese patients with systemic lupus erythematosus |
| Q34063153 | Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. |
| Q33703372 | Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes |
| Q28506871 | HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin |
| Q36219516 | Harnessing programmed cell death as a therapeutic strategy in rheumatic diseases |
| Q90225438 | Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11chiCD11b+ Dendritic Cells in NZB/W F1 Mice |
| Q35557813 | High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus |
| Q28118997 | High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine |
| Q36861623 | Histone H2AX phosphorylation as a measure of DNA double-strand breaks and a marker of environmental stress and disease activity in lupus |
| Q27026126 | How apoptotic cells aid in the removal of their own cold dead bodies |
| Q90284182 | How macrophages deal with death |
| Q37252438 | Hypothetical review: thymic aberrations and type-I interferons; attempts to deduce autoimmunizing mechanisms from unexpected clues in monogenic and paraneoplastic syndromes |
| Q36016585 | Identification of TLT2 as an engulfment receptor for apoptotic cells |
| Q35175734 | IgG autoantibodies against deposited C3 inhibit macrophage-mediated apoptotic cell engulfment in systemic autoimmunity |
| Q33796991 | Immunobiology of the TAM receptors |
| Q33949907 | Immunogenicity of autoantigens |
| Q91847805 | Immunological pathogenesis and treatment of systemic lupus erythematosus |
| Q35614763 | Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. |
| Q42856687 | Impaired Apoptotic Cell Clearance in the Germinal Center by Mer-Deficient Tingible Body Macrophages Leads to Enhanced Antibody-Forming Cell and Germinal Center Responses |
| Q37950925 | Impaired clearance of apoptotic cells in germinal centers: implications for loss of B cell tolerance and induction of autoimmunity |
| Q36399434 | Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease |
| Q34513422 | Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary Sjögren's syndrome |
| Q35953561 | In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus |
| Q33765614 | Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy. |
| Q35093012 | Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis |
| Q37019629 | Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE |
| Q26796413 | Inflammatory etiopathogenesis of systemic lupus erythematosus: an update |
| Q24296799 | Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes |
| Q90347742 | Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses |
| Q35784689 | Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons |
| Q35014051 | Interferon regulatory factors: critical mediators of human lupus |
| Q35629981 | Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus? |
| Q39011250 | Loading of nuclear autoantigens prototypically recognized by systemic lupus erythematosus sera into late apoptotic vesicles requires intact microtubules and myosin light chain kinase activity. |
| Q38659241 | Lupus erythematosus revisited. |
| Q46428350 | Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus |
| Q39129914 | Macrophages and skeletal health |
| Q35636696 | Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells |
| Q36926240 | Macrophages: Their Emerging Roles in Bone. |
| Q35840704 | Mechanisms of B cell autoimmunity in SLE. |
| Q64085964 | Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy |
| Q37633711 | Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage |
| Q28082840 | Modulation of inflammation by autophagy: Consequences for human disease |
| Q37777065 | Monocyte and Macrophage Abnormalities in Systemic Lupus Erythematosus |
| Q87874504 | Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis |
| Q39144786 | Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview |
| Q89687336 | New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis |
| Q39834656 | Novel approach to improve molecular imaging research: Correlation between macroscopic and molecular pathological findings in patients |
| Q37638952 | Participation of the receptor for advanced glycation end products in efferocytosis |
| Q39379152 | Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective |
| Q24672873 | Pathogenesis of systemic lupus erythematosus |
| Q37038484 | Pathophysiology of cutaneous lupus erythematosus |
| Q46908262 | Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms |
| Q34602983 | Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells |
| Q26766332 | Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer |
| Q37662158 | Phospholipids: key players in apoptosis and immune regulation. |
| Q38178160 | Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. |
| Q37778644 | Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus |
| Q46346251 | Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease |
| Q38573436 | Prix Fixe: Efferocytosis as a Four-Course Meal |
| Q92222878 | Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus |
| Q43156007 | Prolonged apoptotic cell accumulation in germinal centers of Mer-deficient mice causes elevated B cell and CD4+ Th cell responses leading to autoantibody production |
| Q38787457 | Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles |
| Q91676689 | ROCK1 but not LIMK1 or PAK2 is a key regulator of apoptotic membrane blebbing and cell disassembly |
| Q38188456 | Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus |
| Q54571753 | Reduced expression of C1q-mRNA in monocytes from patients with systemic lupus erythematosus. |
| Q35636552 | Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement |
| Q36394974 | Regulation of cytokine production during phagocytosis of apoptotic cells |
| Q37699389 | Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells |
| Q49897721 | Rethinking Phagocytes: Clues from the Retina and Testes |
| Q37822295 | Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis |
| Q36678337 | SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen |
| Q26774797 | SLE-associated risk factors affect DC function |
| Q37103259 | Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications. |
| Q34307379 | Self DNA from lymphocytes that have undergone activation-induced cell death enhances murine B cell proliferation and antibody production |
| Q47912211 | Self-dsDNA in the pathogenesis of systemic lupus erythematosus. |
| Q57253368 | Sialylation of anti-histone immunoglobulin G autoantibodies determines their capabilities to participate in the clearance of late apoptotic cells |
| Q36067728 | Siglec-H protects from virus-triggered severe systemic autoimmunity |
| Q36232679 | Signals from dying cells: tolerance induction by the dendritic cell |
| Q36101523 | Silica-Triggered Autoimmunity in Lupus-Prone Mice Blocked by Docosahexaenoic Acid Consumption |
| Q33909504 | Spontaneous activation of RNA-sensing pathways in autoimmune disease |
| Q40343247 | Spontaneous germinal centers and autoimmunity |
| Q39640328 | Synchronized turbo apoptosis induced by cold-shock |
| Q36673286 | Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. |
| Q79556893 | T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis |
| Q35819380 | TAM receptor signaling in immune homeostasis |
| Q37995556 | TLR7 and TLR9 in SLE: when sensing self goes wrong |
| Q55436021 | The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes. |
| Q41824557 | The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells |
| Q52668322 | The Neutrophil's Choice: Phagocytose vs Make Neutrophil Extracellular Traps. |
| Q34040376 | The Pathogenesis of Lupus Nephritis |
| Q64897993 | The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review. |
| Q91595744 | The clearance of dead cells by efferocytosis |
| Q33878890 | The evolution of human anti-double-stranded DNA autoantibodies |
| Q30529641 | The lupus-prone NZM2410/NZW strain-derived Sle1b sublocus alters the germinal center checkpoint in female mice in a B cell-intrinsic manner |
| Q39277496 | The many ways tissue phagocytes respond to dying cells |
| Q35557606 | The putative role of apoptosis-modified histones for the induction of autoimmunity in Systemic Lupus Erythematosus |
| Q43100973 | The regulation of autoreactive B cells during innate immune responses |
| Q33754111 | The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus |
| Q37739807 | The role of defective clearance of apoptotic cells in systemic autoimmunity. |
| Q30429149 | The role of nucleotides in apoptotic cell clearance: implications for disease pathogenesis |
| Q34759804 | The role of the macrophage in apoptosis: hunter, gatherer, and regulator |
| Q46342472 | Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Apoptotic Cells |
| Q26866179 | Tumor immunotherapy: lessons from autoimmunity |
| Q54339984 | Unconventional apoptosis of polymorphonuclear neutrophils (PMN): staurosporine delays exposure of phosphatidylserine and prevents phagocytosis by MΦ-2 macrophages of PMN. |
| Q36578796 | Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity |
| Q57023308 | [Pathogenesis of systemic lupus erythematosus] |
| Q82672538 | [The role of incomplete clearance of apoptotic cells in the etiology and pathogenesis of SLE] |
Search more.